Treating chromoblastomycosis with systemic antifungals

A Bonifaz, V Paredes-Solís, A Saúl - Expert opinion on …, 2004 - Taylor & Francis
Chromoblastomycosis is a subcutaneous mycosis for which there is no treatment of choice
but rather, several treatment options, with low cure rates and many relapses. The choice of …

Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment

F Queiroz-Telles, P Esterre, M Perez-Blanco… - Medical …, 2009 - academic.oup.com
Chromoblastomycosis is one of the most frequent infections caused by melanized fungi. It is
a subcutaneous fungal infection, usually an occupational related disease, mainly affecting …

Management of chromoblastomycosis: novel perspectives

P Esterre, F Queiroz-Telles - Current opinion in infectious diseases, 2006 - journals.lww.com
Management of chromoblastomycosis: novel perspectives : Current Opinion in Infectious Diseases
Management of chromoblastomycosis: novel perspectives : Current Opinion in Infectious …

Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both

A Bonifaz, E Martínez‐Soto… - International journal …, 1997 - Wiley Online Library
Background Chromoblastomycosis is a subcutaneous mycosis, seen frequently in tropical
areas, and caused by dematiaceous fungi. It produces nodulo‐verrucous lesions in the arms …

[HTML][HTML] Chromoblastomycosis: a neglected tropical disease

F Queiroz-Telles - Revista do Instituto de Medicina Tropical de São …, 2015 - SciELO Brasil
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous
tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous …

Chromoblastomycosis

E Torres-Guerrero, R Isa-Isa, M Isa, R Arenas - Clinics in dermatology, 2012 - Elsevier
Chromoblastomycosis is a chronic, subcutaneous mycosis, characterized by verrucous
nodular lesions, usually involving the legs and mainly caused by Fonsecaea, Phialophora …

In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: a systematic review

AH da Silva Hellwig, D Heidrich, RA Zanette… - Journal of global …, 2019 - Elsevier
Chromoblastomycosis (CBM) is a chronic granulomatous mycosis caused by dematiaceous
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …

Chromoblastomycosis: clinical presentation and management

M Ameen - Clinical and experimental dermatology, 2009 - academic.oup.com
Chromoblastomycosis is an important subcutaneous mycotic infection that is endemic
worldwide but more common in the tropics. It is caused by the traumatic inoculation of the …

Chromoblastomycosis

RL Martínez, LJM Tovar - Clinics in dermatology, 2007 - Elsevier
Chromoblastomycosis is a chronic subcutaneous mycotic infection caused by pigmented or
dematiaceous saprophytic moulds ubiquitous in the environment. The most common …

SUCCESSFUL TREATMENT OF CHROMOBLASTOMYCOSIS DUE TO FONSECAEA PEDROSOI BY THE COMBINATION OF ITRACONAZOLE AND …

P Kullavanijaya, V Rojanavanich - International journal of …, 1995 - Wiley Online Library
Background. Many methods and medications had been tried for the treatment of
chromoblastomycosis with unsatisfactory results. Recently, there were several reports …